1. Talasaz, A.H., H. Khalili, F. Fahimi, Y. Jenab, M.A. Broumand, M. Salarifar and F. Darabi, 2013. Effects of N-acteylcystein on the cardiac remodeling and major adverse events following AMI: A randomized clinical trial. Am. J. Cardiovasc. Drugs .
2. Khalilzadeh, S., M. Hassanzad, N. Baghaie, N. Parsanejad, M.R. Boloursaz and F. Fahimi, 2013. Shwachman score in clinical evaluation of cystic fibrosis. J. Comprehen. Pediatrics, 3: 82-85.
   Direct Link  |  
3. Fahimi, F., P. Tabarsi, F. Kobarfard, D.B. Bozorg and A. Goodarzi et al., 2013. Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis. Int. J. Tuberc. Lung. Dis., 17: 1602-1606.
   CrossRef  |  Direct Link  |  
4. Fahimi, F., P. Adimi, S.A. Nadji, N. Naderi, S. Morowati, F. Soleimani and M.R. Masjedi, 2013. The effect of polymorphisms of Beta2 adrenoceptors on response to long-acting beta2 agonists in iranian asthmatic patients. Iran. J. Allergy Asthma Immunol., 12: 383-390.
   PubMed  |  Direct Link  |  
5. Fahimi, F., F. Soleymani and M. Tavakoli-Ardakani, 2013. Vancomycin utilization evaluation in a teaching hospital: A case- series study in Iran. J. Pharm. Care, 1: 51-54.
   Direct Link  |  
6. Baniasadi, S., A. Dorudinia, M. Mobarhan, M.K. Gamishan and F. Fahimi, 2013. Microbial contamination of single- and multiple-dose vials after opening in a pulmonary teaching hospital. Braz. J. Infect. Dis., 17: 69-73.
   CrossRef  |  PubMed  |  Direct Link  |  
7. Allameh, Z., M. Mehrpooya, S. Baniasadi and F. Fahimi, 2013. Clinical pharmacy services in an Iranian teaching hospital: Type, severity, resolution and accuracy. J. Res. Pharm. Pract., 2: 10-17.
   CrossRef  |  Direct Link  |  
8. Adimi Naghan, P., F. Fahimi, S.A. Nadji, N. Naderi, F. Soleimani and M.R. Masjedi, 2013. A pilot study of polymorphism of adrenergic beta-2 receptor and mild asthma: A clinical and pharmacogenetic study. Iran. J. Pharm. Res., 12: 199-204.
   PubMed  |  Direct Link  |  
9. Talasaz, A.H., F. Fahimi, Z. Jahangard-Rafsanjani and S. Ziaie, 2012. Evaluation of the pattern of human albumin utilization at a university affiliated hospital. Arch. Iran. Med., 15: 85-87.
   PubMed  |  Direct Link  |  
10. Mohammad, M.M., F. Fahimi, A. Fakharian, M.K. Gamishan, M. Sistanizad, N. Fayazi and S. Khalilzadeh, 2012. Methacoline challenge test as an evaluator of response to statins in bronchial hyperresponsiveness. Iran. J. Pharm. Res., 11: 969-977.
    PubMed  |  Direct Link  |  
11. Foroughinia, F., S. Seifi, S. Baniasadi and F. Fahimi, 2012. Vincristine-induced seizure potentiated by itraconazole following RCHOP chemotherapy for diffuse large B-cell lymphoma. Curr. Drug Safety, 7: 372-374.
    CrossRef  |  PubMed  |  
12. Fahimi, F., S. Hashemian, S. Baniasadi, S. Ghafari and P. Tabarsi et al., 2012. Clinical efficacy of bolus versus continuous-infusion of piperacillin-tazobactam in VAP treatment. Indian J. Crit. Care., 16: 141-147.
13. Fahimi, F., S. Emami and F.R. Farrokhi, 2012. The rate of antibiotic dosage adjustment in renal dysfunction. Iran. J. Pharm. Res., 11: 157-161.
    PubMed  |  Direct Link  |  
14. Fahimi, F., S. Baniasadi, A. Mortazavi, H. Dehghan and A. Zarghi, 2012. Physical and chemical stability of mycophenolate mofetil (MMF) suspension prepared at the hospital. Iran. J. Pharm. Res., 11: 171-175.
15. Fahimi, F., 2012. How medical representatives influence prescribers behaviour? Iran. J. Pharm. Res., 11: 383-384.
16. Emami, S., H.R. Esfahani, F.F. Rashid and F. Fahimi, 2012. Assessment of drug dose adjustment in patients with kidney disease at a tertiary care hospital: Opportunities for pharmacist involvement. Int. J. Pharm. Pharm. Sci., 4: 178-181.
    Direct Link  |  
17. Baniasadi, S., F. Fahimi and F. Kobarfard, 2012. Extemporaneous preparation and stability assessment of omeprazole suspension in a teaching hospital. Int. J. Pharm. Teach. Pract., 3: 418-421.
    Direct Link  |  
18. Ziaie, S., H. Jamaati, M. Hajimahmoodi, S.M. Hashemian and F. Fahimi et al., 2011. The relationship between vitamin E plasma and BAL concentrations, SOD activity and ventilator support measures in critically III patients. Iran. J. Pharm. Res., 10: 953-960.
    PubMed  |  Direct Link  |  
19. Talasaz, A.H., H. Khalili, F. Fahimi and M. Salarifar, 2011. Potential role of N-acetylcysteine in cardiovascular disorders. Therapy, 8: 237-245.
    CrossRef  |  Direct Link  |  
20. Hashemian, S.M., N. Cahill, L. Murch, M. Wang and H. Jamaati et al., 2011. Improving the practice of nutrition therapy in the NRITLD critically III patients: An international quality improvement project. Tanaffos, 10: 31-37.
    Direct Link  |  
21. Fahimi, F., Z. Sahraee and S. Amini, 2011. Evaluation of stat orders in a teaching hospital. Clin. Drug Investigat., 31: 231-235.
    CrossRef  |  PubMed  |  Direct Link  |  
22. Fahimi, F., S. Amini, K. Khodadad, F. Naghibi, J. Salamzadeh and S. Baniasadi, 2011. Evaluating the effect of Zingiber officinalis on nausea and vomiting in patients receiving cisplatin based regimens. Iran. J. Pharm. Res., 10: 379-384.
    PubMed  |  Direct Link  |  
23. Fahimi, F., F. Kobarfard, P. Tabarsi, S. Hemmati, S. Baniasadi and J. Salamzadeh, 2011. Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis referral center. Chemotherapy, 57: 7-11.
    CrossRef  |  PubMed  |  Direct Link  |  
24. Fahimi, F., F. Kobarfard, J. Salamzadeh, A. Fakharian and P. Abdollahi et al., 2011. The comparison between two common types of spacers in respiratory indices alteration (FEV1) and the bioavailability of albuterol using urine specimen of asthmatic patients in Masih Daneshvari Hospital. World Allergy Org. J., 4: 179-183.
25. Baniasadi, S. and F. Fahimi, 2011. Adverse drug reactions in a pulmonary teaching hospital: incidence, pattern, seriousness and preventability. Curr. Drug Safety, 6: 230-236.
    CrossRef  |  PubMed  |  
26. Tavallaee, M., F. Fahimi and S. Kiani, 2010. Drug-use patterns in an intensive care unit of a hospital in Iran: An observational prospective study. Int. J. Pharm. Pract., 18: 370-376.
    CrossRef  |  PubMed  |  Direct Link  |  
27. Fahimi, F., M. Sistanizad, R. Abrishami and S. Baniasadi, 2010. An observational study of errors related to the preparation and administration of medications given by infusion devices in a teaching hospital. Iran. J. Pharm. Res., 6: 295-299.
    Direct Link  |  
28. Fahimi, F., B. Sharif-Kashani, Z. Hossein-Ahmadi, J. Salamzadeh and R. Namdar et al., 2010. The first pharmacist-based warfarin-monitoring service in Iran. J. Pharma. Health Serv. Res., 2: 59-62.
    CrossRef  |  Direct Link  |  
29. Fahimi, F., 2010. Implementation of a clinical pharmacy education program in a teaching hospital: Resident oriented documentation and intervention. Iran. J. Pharm. Res., 9: 297-302.
    Direct Link  |  
30. Baniasadi, S., S. Beizaee, B. Kazemi, N. Behzadnia, B. Shafaghi, M. Bandehpour and F. Fahimi, 2010. Novel VKORC1 mutations associated with warfarin sensitivity. Cardiovasc Ther., 29: e1-e5.
    CrossRef  |  PubMed  |  
31. Baniasadi, S., P. Eftekhari, P. Tabarsi, F. Fahimi, M.R. Raoufy, M.R. Masjedi and A.A. Velayati, 2010. Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur. J. Gastroenterol. Hepatol., 22: 1235-1238.
    CrossRef  |  PubMed  |  
32. Baghaei, P., P. Tabarsi, E. Chitsaz, M. Saleh and M. Marjani et al., 2010. Incidence, clinical and epidemiological risk factors and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. Am. J. Ther., 17: 17-22.
    CrossRef  |  PubMed  |  
33. Sakhaiyan, E., M. Hadjibabaie, K. Gholami, F. Fahimi and A.R. Shamshiri et al., 2009. Drug utilization evaluation of imipenem in patients undergoing bone marrow transplantation. Int. J. Hematol. Oncol. Stem Cell Res., 3: 10-13.
    Direct Link  |  
34. Fahimi, F., S. Baniasadi and K. Najafizadeh, 2009. Dose switch to another dosage form of Neoral increase the risk of medication error? Ann. Transplant., 14: 58-60.
    PubMed  |  Direct Link  |  
35. Fahimi, F., M.A. Nazari, R. Abrishami, M. Sistanizad and T. Mazidi et al., 2009. Transcription errors observed in a teaching hospital. Arch. Iran. Med., 12: 173-175.
    PubMed  |  
36. Fahimi, F., J. Salamzadeh, H. Jamaati, S. Sohrabi, A. Fakharian and Z. Mohammadtaheri, 2009. Do statins improve lung function in asthmatic patients? A randomized and double-blind trial. Iran. J. Pharma. Sci. Winter, 5: 13-20.
37. Dezfouli, A.A., K. Najafizadeh, T. Parsa, M.B. Shadmehr and S. Dabir et al., 2009. Postlung transplant rehospitalization: a study of causes, health care burden and outcomes. Exp. Clin. Transplant., 7: 192-196.
    PubMed  |  Direct Link  |  
38. Baniasadi, S., F. Fahimi and R. Namdar, 2009. Development of an adverse drug reaction bulletin in a teaching hospital. Formulary, 44: 333-335.
    Direct Link  |  
39. Fakharian, A., F. Fahimi, J. Salamzadeh, M. Mohammadi and M. Reza, 2008. Spirometric improvements with two commonly used spacers in asthmatic patients. Tanaffos, 7: 37-40.
    Direct Link  |  
40. Fahimi, F., S. Baniasadi, N. Behzadnia, F. Varahram and L.G. Tabatabaie, 2008. Enoxaparine utilization evaluation:an observatioinal prospective study in medical inpatients. Iran. J. Pharm. Res., 7: 77-82.
41. Fahimi, F., S. Baniasadi and S. Amini, 2008. Adverse drug reactions in the post coronary care unit inpatients of a teaching hospital. Iran. J. Pharm. Res., 7: 223-228.
    Direct Link  |  
42. Fahimi, F., P. Ariapanah, M. Faizi, B. Shafaghi, R. Namdar and M.T. Ardakani, 2008. Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: An education program: Resident observational study. Aust. Crit. Care., 21: 110-116.
43. Baniasadi, S., F. Fahimi and G. Shalviri, 2008. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin. Pharm. Toxicol., 102: 408-411.
    CrossRef  |  Direct Link  |  
44. Fahimi, F., S. Baniasadi and M. Malekmohammad, 2007. Neurologic and psychotic reaction induced by lidocaine. J. Bronchol. Interventional Pulmonol., 14: 57-58.
    CrossRef  |  
45. Fahimi, F., M. Moradi, T. Safarnavadeh and R. Namdar, 2007. Management of community acquired pneumonia in a teaching hospital: The role of established guidelines. Tanaffos, 6: 32-37.
    Direct Link  |  
46. Fahimi, F., 2007. Should clinical services provided by pharmacists be compensated? Iran. J. Pharm. Res., 6: 1-2.
47. Baniasadi, S., F. Fahimi and D. Mansouri, 2007. Serum sickness-like reaction associated with cefuroxime and ceftriaxone. Ann. Pharm., 41: 1318-1319.
48. Richard, B., F. Fahimi and N. Naderi, 2005. Improving risk factors in diabetic patients participating in a weight management program. Southern Med. J., 98: 496-497.
49. Ahmadi-Abhari, S.A., A.R. Dehpour, M. Sadeghi, M. Noroozian and A. Farhoodian et al., 2005. Lithium erythrocyte concentration and neurological toxicity in bipolar disorder. J. Pharmacy Practice Res., 35: 103-105.
    Direct Link  |  
50. Dashti-Khavidaki, S., S.A. Ahmadi-Abhari, P. Ghaeli, H. Farsam and A.R. Dehpour et al., 2003. Relationship between erythrocyte lithium concentration and renal concentrating capacity. J. Clin. Pharm. Ther., 28: 451-456.
    CrossRef  |  
51. Ahmadi-Abhari, S.A., P. Ghaeli, F. Fahimi, F. Esfahanian and H. Farsam et al., 2003. Risk factors of thyroid abnormalities in bipolar patients receiving lithium: A case control study. BMC Psychiatry, Vol. 3. 10.1186/1471-244X-3-4.
    CrossRef  |  
52. Fahimi, F., F. Siavoshi and S. Ala, 2002. Effect of pretreatment with ethanol or ammonium hydroxide on helicobacter pylori colonization in the stomach of rats. Acta Med. Iranica, 40: 33-37.
    Direct Link  |